These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 25710482)

  • 1. Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation.
    Szelag M; Czerwoniec A; Wesoly J; Bluyssen HA
    PLoS One; 2015; 10(2):e0116688. PubMed ID: 25710482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative screening and validation as a novel tool to identify STAT-specific inhibitors.
    Szeląg M; Czerwoniec A; Wesoly J; Bluyssen HA
    Eur J Pharmacol; 2014 Oct; 740():417-20. PubMed ID: 25183399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico simulations of STAT1 and STAT3 inhibitors predict SH2 domain cross-binding specificity.
    Szelag M; Sikorski K; Czerwoniec A; Szatkowska K; Wesoly J; Bluyssen HA
    Eur J Pharmacol; 2013 Nov; 720(1-3):38-48. PubMed ID: 24211327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring dual inhibitors for STAT1 and STAT5 receptors utilizing virtual screening and dynamics simulation validation.
    Raj U; Kumar H; Gupta S; Varadwaj PK
    J Biomol Struct Dyn; 2016 Oct; 34(10):2115-29. PubMed ID: 26471877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease.
    Szelag M; Piaszyk-Borychowska A; Plens-Galaska M; Wesoly J; Bluyssen HA
    Oncotarget; 2016 Jul; 7(30):48788-48812. PubMed ID: 27166190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-Wide Inhibition of Pro-atherogenic Gene Expression by Multi-STAT Targeting Compounds as a Novel Treatment Strategy of CVDs.
    Plens-Galaska M; Szelag M; Collado A; Marques P; Vallejo S; Ramos-González M; Wesoly J; Sanz MJ; Peiró C; Bluyssen HAR
    Front Immunol; 2018; 9():2141. PubMed ID: 30283459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Inhibition of STAT3 with Respect to STAT1: Insights from Molecular Dynamics and Ensemble Docking Simulations.
    Yesylevskyy SO; Ramseyer C; Pudlo M; Pallandre JR; Borg C
    J Chem Inf Model; 2016 Aug; 56(8):1588-96. PubMed ID: 27479469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
    Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
    Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in signal transducer and activator of transcription 3 (STAT3) dynamics induced by complexation with pharmacological inhibitors of Src homology 2 (SH2) domain dimerization.
    Resetca D; Haftchenary S; Gunning PT; Wilson DJ
    J Biol Chem; 2014 Nov; 289(47):32538-47. PubMed ID: 25288792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of phosphopeptide motifs specific for the Src homology 2 domains of signal transducer and activator of transcription 1 (STAT1) and STAT3.
    Wiederkehr-Adam M; Ernst P; Müller K; Bieck E; Gombert FO; Ottl J; Graff P; Grossmüller F; Heim MH
    J Biol Chem; 2003 May; 278(18):16117-28. PubMed ID: 12591923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoform selective inhibition of STAT1 or STAT3 homo-dimerization via peptidomimetic probes: structural recognition of STAT SH2 domains.
    Gunning PT; Katt WP; Glenn M; Siddiquee K; Kim JS; Jove R; Sebti SM; Turkson J; Hamilton AD
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1875-8. PubMed ID: 17336521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for the binding of high affinity phosphopeptides to Stat3.
    McMurray JS
    Biopolymers; 2008; 90(1):69-79. PubMed ID: 18058821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel small molecules that inhibit STAT3-dependent transcription and function.
    Kolosenko I; Yu Y; Busker S; Dyczynski M; Liu J; Haraldsson M; Palm Apergi C; Helleday T; Tamm KP; Page BDG; Grander D
    PLoS One; 2017; 12(6):e0178844. PubMed ID: 28636670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of molecular recognition of STAT3 SH2 domain inhibitors through molecular simulation.
    Park IH; Li C
    J Mol Recognit; 2011; 24(2):254-65. PubMed ID: 21360612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT-3 inhibitors: state of the art and new horizons for cancer treatment.
    Lavecchia A; Di Giovanni C; Novellino E
    Curr Med Chem; 2011; 18(16):2359-75. PubMed ID: 21568920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening.
    Liu LJ; Leung KH; Chan DS; Wang YT; Ma DL; Leung CH
    Cell Death Dis; 2014 Jun; 5(6):e1293. PubMed ID: 24922077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient killing of SW480 colon carcinoma cells by a signal transducer and activator of transcription (STAT) 3 hairpin decoy oligodeoxynucleotide--interference with interferon-gamma-STAT1-mediated killing.
    Tadlaoui Hbibi A; Laguillier C; Souissi I; Lesage D; Le Coquil S; Cao A; Metelev V; Baran-Marszak F; Fagard R
    FEBS J; 2009 May; 276(9):2505-15. PubMed ID: 19476491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the roles of STAT1 and STAT3 signal transduction pathways in mammalian lens development.
    Ebong S; Chepelinsky AB; Robinson ML; Zhao H; Yu CR; Egwuagu CE
    Mol Vis; 2004 Feb; 10():122-31. PubMed ID: 14978477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel STAT3 small-molecule inhibitors identified by structure-based virtual ligand screening incorporating SH2 domain flexibility.
    Kong R; Bharadwaj U; Eckols TK; Kolosov M; Wu H; Cruz-Pavlovich FJS; Shaw A; Ifelayo OI; Zhao H; Kasembeli MM; Wong STC; Tweardy DJ
    Pharmacol Res; 2021 Jul; 169():105637. PubMed ID: 33932608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical probes that competitively and selectively inhibit Stat3 activation.
    Xu X; Kasembeli MM; Jiang X; Tweardy BJ; Tweardy DJ
    PLoS One; 2009; 4(3):e4783. PubMed ID: 19274102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.